HC Wainwright Reaffirms “Buy” Rating for CG Oncology (NASDAQ:CGON)
HC Wainwright reiterated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note released on Tuesday morning, Benzinga reports. The brokerage currently has a $75.00 target price on the stock. Several other research firms also recently commented on CGON. Bank of America assumed coverage on CG Oncology in a […]
More Stories
Disney to Pay $10 Million to Resolve Children’s Privacy Claims
By Bill Pan Disney will pay $10 million to settle allegations that it violated a federal children’s privacy law through...
Federal Reserve Minutes Reflect Ongoing Divergence Over Interest Rates
By Andrew Moran The Federal Reserve’s December meeting proved far more fractured than the final vote suggested, underscoring the persistent...
US, Allied Forces Have Killed or Captured More Than 2 Dozen ISIS Operatives in Syria
By Jacob Burg The United States and its partner forces have captured or killed nearly 25 operatives of the ISIS...
Beijing Invokes ‘Make America Great Again’ in Rare Bid to Ease US Tensions
By Michael Zhuang From Dec. 26 to 29, Chinese state media published a rare series of editorials striking a conciliatory...
Judge Blocks White House’s Attempt to Defund Consumer Watchdog Agency
By Jack Phillips A federal judge ruled Tuesday that the White House cannot lapse its funding of the Consumer Financial...
Top 11 Hottest News Anchors in the World of All Time
News anchors have become a part of global personality. They are no longer just people who read headlines. Now, viewers...